¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Menopausal and perimenopausal disorder, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • temperature-dependent skin disorder
    ¿ÂµµÀÇÁ¸ÇǺκ´
  • thinking disorder
    »ý°¢Àå¾Ö, »ç°íÀå¾Ö
  • tic disorder
    ƽÀå¾Ö, ƽº´
  • tobacco-related disorder
    ´ã¹è°ü·ÃÀå¾Ö
  • unipolar disorder
    Ȭ±ØÀå¾Ö, Ȭ±Øº´
  • vascular disorder
    Ç÷°üÁúȯ, Ç÷°üÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • wear and tear
    ¼Ò¸ð(á¼ÙÄ)
  • wear and tear dermatitis
    ¹Ýº¹ÀÚ±Ø ÇǺο°
  • wear and tear pigment
    ¼Ò¸ð»ö¼Ò(¡­ßäáÈ).
  • wear and tear quota
    ¼Ò¸ðºÐ(á¼ÙÄÝÂ).
  • wet and dry bulb thermometer
    °Ç½À±¸¿Âµµ°è(˧ËàË´Ëí̬˭).
  • white matter (tracts and fascicles)
    ¹é»öÁú(½Å°æ·Î¿Í ½Å°æ´Ù¹ß)
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö (¡­Òàî¡äô).
  • acute polymorphic psychotic disorder
    ±Þ¼º ´ÙÇü¼º Á¤½ÅÁõÀû Àå¾Ö(º´)
  • acute stress disorder
    ±Þ¼º ½ºÆ®·¹½º Àå¾Ö(º´)
  • adjustment disorder
    ÀûÀÀÀå¾Ö(º´)
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö(º´), ¼ö¸é Á¶Á¤ Àå¾Ö(º´)
  • affective disorder
    °¨µ¿¼º Á¤½Åº´, Á¤µ¿¼º Á¤½ÅÀå¾Ö(¡­ïñãêî¡äô).
  • allergic disorder
    ¾Ë·¹¸£±â(¼º) Áúȯ.
  • amnestic disorder
    ±â¾ï»ó½ÇÀå¾Ö(º´)
  • antisocial personality disorder
    ¹Ý»çȸ¼º ÀΰÝÀå¾Ö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
OCPD obsessive compulsive personality disorder
ODD oculodentodigital [dysplasia]; oppositional defiant disorder
OMD ocular muscle dystrophy; oculomandibulodyscephaly; organic mental disorder; oromandibular dystonia
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
PDD pervasive developmental disorder; platinum diamminodichloride [cisplatin]; primary degenerative deme...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
RBD REM sleep behavior disorder
SAD SEASONAL AFFECTIVE DISORDER
SPD Schizotypal Personality Disorder
SD Somatization disorder
TDI Thought Disorder Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • psychogenic pain disorder
    ½É¸®Àû ÅëÁõ Àå¾Ö, Á¤½ÅÀû ÅëÁõ Àå¾Ö, ½ÉÀμº ÅëÁõÀå¾Ö
    µ¿ÀǾî=
  • psychophysiology disorder
    Á¤½Å »ý¸® Áúȯ
  • psychosomatic disorder
    ½É½Å¼º Àå¾Ö, Á¤½Å ½Åü Áúȯ
  • reticuloendothelial disorder
    ¼¼¸Á ³»Çǰè Áúȯ
  • rheumatologic disorder
    ·ù¸¶Æ¼¼º Àå¾Ö, ·ù¸¶Æ¼½º Àå¾Ö
  • schizoaffective disorder
    ºÐ¿­ Á¤µ¿Çü Àå¾Ö
    Á¤½Å ºÐ¿­Áõ°ú °¨Á¤ Àå¾Ö, ¿¹¸¦ µé¾î Á¶ÁõÀ̳ª ¿ì¿ïÁõ µî ¾çÂÊ Áõ»óÀ» ´Ù °®°í ÀÖ´Â Á¤½Å Àå¾ÖÀÇ Áø´Ü¸í.
  • schizoid disorder
    ºÐ¿­º´ ºÎÁ¶
  • schizophreniform disorder
    Á¤½Å ºÐ¿­Çü Àå¾Ö
    Áõ»óÀ̳ª ÁõÈÄ´Â Á¤½Å ºÐ¿­ÁõÀ» °¡Áö°í ÀÖÀ¸³ª ±× ±â°£ÀÌ 6°³¿ù¿¡ ¹ÌÄ¡Áö ¸øÇÏ´Â Á¤½Å Àå¾Ö. Àü¿¡´Â ±Þ¼º Á¤½Å ºÐ¿­ÁõÀ̶ó°í ºÒ·¶´Ù.
  • secondary disorder
    ÀÌÂ÷ Àå¾Ö
  • skin disorder
    ÇǺΠÁúȯ
  • sleep terror disorder
    ¾ß°æ Àå¾Ö
    ÀáµéÀÚ °ð Àá¿¡¼­ ±ú¾î³ª °­ÇÑ ºÒ¾È°ú ÀÚÀ²½Å°æ °èÅëÀÇ Áõ»óµéÀÌ ³ªÅ¸³ª ¾Æ¹«¸® ÁøÁ¤½ÃŰ·Á ÇØµµ Àß µèÁö ¾Ê´Â »óŰ¡ µÇÇ®ÀÌÇÏ¿© ÀϾ´Â °Í.
  • somatic disorder
    ½Åü Àå¾Ö
  • somatization disorder
    ½Åüȭ Àå¾Ö
    Áø´Ü¸íÀ¸·Î, ÀüÇüÀûÀÎ È÷½ºÅ׸® ¶Ç´Â ºê¸®ÄÉ ÁõÈıºÀÌ ¾Æ´Ñ ´Ù¹ßÀû ½Åü Áõ»ó È£¼Ò°¡ Ư¡ÀÎ Á¤½Å Àå¾Ö, º´¼ÒÀÇ ³»¿ëÀº Àü¹ÝÀûÀ¸·Î ÀÚÁÖ ¿©±âÀú±â Àß ¾ÆÇÁ´Ù´Â °Í°ú °¡½Å°æÇÐÀûÀΠƯ¼öÇÑ Àüȯ Áõ»ó, ¼ÒÈ­±â°è Áõ»ó, ¿©¼º »ý½Ä±â°è Áõ»ó, Á¤½Å¼º Áõ»ó, ½ÉÆó°è Áõ»ó ¹× ÅëÁõ µîÀÌ´Ù. º´¼Ò´Â °¡²û ±ØÀûÀÌ°í ¸ðÈ£ÇÏ¸ç °úÀåµÈ ÇüÅ·ΠǥÇöµÈ´Ù. ¸¹Àº ÀÇ»çµéÀÌ ÀÌ È¯ÀÚÀÇ ÀÇÇÐÀû Ä¡·á¿¡ °³ÀԵǰí, ¼ö¾øÀÌ ¸¹Àº Áø´Ü °úÁ¤°ú ÇÊ¿ä ¾ø´Â ³»°úÀû Ä¡·á ¶Ç´Â ¼ö¼ú±îÁö ÇÏ°Ô µÈ´Ù. ´ëºÎºÐÀÇ È¯ÀÚµéÀº ºÒ¾È, ¿ì¿ï ¶Ç´Â ±¤¹üÀ§ÇÑ ´ëÀÎ °ü°èÀÇ ¾î·Á¿òÀÌ ÀÖ°í ´ëºÎºÐÀÌ È÷½ºÅ׸®¼º ÀÎ°Ý Æ¯¼ºÀ» °®°í ÀÖ´Ù.
  • somatoform disorder
    ½Åü Àå¾Ö, ½ÅüÇü Àå¾Ö, ½Åüȭ Àå¾Ö
    ±âÁúÀû ¼Ò°ßÀÌ ¾ø´Â ½Åü ÁúȯÀ» ³ªÅ¸³»´Â Áõ»óÀÌ ÀÖ´Â Á¤½ÅÀû »óÅ·μ­ ÀÓ»óÀûÀ¸·Î ÀûÀÀ¼º ±â´É¿¡ ½ÉÇÑ Àå¾ÖÀÇ ¿øÀÎÀÌ µÈ´Ù. DSM-VI´Â ÀÌ·¯ÇÑ Àå¾Ö¿¡ 5°¡Áö°¡ ÀÖ´Ù´Â °ÍÀ» ¾Ë·ÁÁØ´Ù. Áï ½Åüȭ Àå¾Ö
  • somatoform pain disorder
    ½ÅüÇü ÅëÁõ Àå¾Ö
    ÁÖµÈ È£¼Ò°¡ ½ÉÇÑ ¸¸¼º ÅëÁõÀ̰í Àüȯ Àå¾ÖÀÇ Áø´Ü ±âÁØ¿¡ ¸Â´Â °ÍÀÌ Æ¯Â¡ÀÎ Á¤½Å Àå¾Ö. ƯÈ÷, ÅëÁõÀÌ ½Å°æ ÇØºÎ³ª ÀÌ¹Ì ¾Ë·ÁÁø º´»ý¸®ÇÐÀû ±âÀü¿¡ ÀÏÄ¡µÇÁö ¾Ê°í ±âÁúÀû º´¸®ÀÇ º¯È­°¡ ÀÖ´Ù ÇÏ´õ¶óµµ ÅëÁõÀÌ ¿¹»óº¸´Ù ÈξÀ ¸¹°Å³ª ¶Ç´Â Áõ»óµéÀÌ ½É¸®Àû ¿øÀÎÀ» ¸í½ÃÇÏ´Â ÁõÈĸ¦ °®°í ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
growth and embryonic development Developmental processes from cell division to embryogenesis to postnatal growth and maturity.
(12 Dec 1998)
grunstein and hogness method The Grunstein and Hogness methodis a hybridisation lab technique in which whole, lysed (ruptured) bacterial colonies which have previously been blotted onto a nitrocellulose (or other) membrane are hybridised to a DNA probe.
(09 Oct 1997)
chondroitinases and chondroitin lyases <enzyme> Enzymes which catalyze the elimination of glucuronate residues from chondroitin a,b, and c or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-d-galactose 6-sulfate units of chondroitin sulfate.
Registry number: EC 4.2.2.-
(12 Dec 1998)
gyrate atrophy of choroid and retina A slowly progressive atrophy of the choriocapillaris, pigmentary epithelium, and sensory retina, with irregular confluent atrophic areas and an associated ornithinuria; autosomal recessive inheritance; due to a deficiency of ornithine d-aminotransferase.
(05 Mar 2000)
pharmacy and therapeutics committee An advisory group composed primarily of staff physicians and the pharmacist which serves as the communication link between the medical staff and the pharmacy department.
(12 Dec 1998)
Rowntree and Geraghty test An obsolete test for renal function; after the patient has drunk a glass or two of water, 1 ml of a 0.6% solution of dye is injected hypodermically; the time between this injection and the appearance of a pink tinge in the urine as it falls into an alkaline solution is noted; the amount excreted in each of the next 2 hours is then estimated colourimetrically.
Synonym: Geraghty's test, phthalein test, red test, Rowntree and Geraghty test.
(05 Mar 2000)
circulatory and respiratory physiology Functions and activities of cardiovascular circulation and of respiration and respiratory mechanics.
(12 Dec 1998)
civilian health and medical program of the uniformed services See: CHAMPUS.
(12 Dec 1998)
clasped thumbs and mental retardation A syndrome with the following characteristic features: (1) neurologically:mental retardation and aphasia (lack of speech); (2) limbs: adducted (clasped) thumbs, absent extensor pollicis longus and/or brevis muscles to the thumb, shuffling gait, and leg spasticity; (3) growth: small body size; (4) skeleton: lumbar lordosis (sway back). The syndrome is inherited as an X-linked trait and so affects mainly boys. Alternative names include MASA syndrome (MASA stands for mental retardation, aphasia, shuffling gait, and adducted thumbs), adducted thumb with mental retardation, congenital clasped thumb with mental retardation, and the Gareis-Mason syndrome.
(12 Dec 1998)
missions and missionaries To be used for articles pertaining to medical activities carried out by personnel in institutions which are administered by a religious organization.
(12 Dec 1998)
physical education and training Instructional programs in the care and development of the body, often in schools. The concept does not include prescribed exercises, which is exercise therapy.
(12 Dec 1998)
coccidia of sheep and goats Eimeria ovina (arloingi), the most common and destructive species in sheep, principal losses being in young lambs; Eimeria minakolyakimovae, a highly pathogenic parasite of sheep; Eimeria parva and Eimeria pallida are frequently found but believed to be of low virulence; Eimeria faurei, Eimeria intricata, Eimeria granulosa, Eimeria ahsata, Eimeria hawkins, Eimeria gilruthi, Eimeria gonzalezi, Eimeria christenseni, Eimeria punctata, Eimeria crandallis, and Eimeria honessi, are found in sheep or goats, and are probably of low pathogenicity. All of these species invade the epithelium of the small intestine.
Synonym: coccidia of sheep and goats.
(05 Mar 2000)
pin and ligature cutter <dentistry> A special plier use to cur off arch wires, ligatures etc.
(08 Jan 1998)
monocyte chemotactic and activating factor Cytokine of the C C subfamily, co induced with IL-8 on stimulation of endothelial cells, fibroblasts or monocytes that activates and is chemotactic for, monocytes. A chemokine.
(18 Nov 1997)
weal and flare <immunology> The vascular changes in the skin in response to mild mechanical injury, an outward spreading zone of reddening flare) followed rapidly by a weal (swelling) at the site of injury.
Redness, heat and swelling, three of the cardinal signs of inflammation, are present.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á